SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 15.80% in the revenue at Rs. 1310.06 millions was reported in the June 2022 quarter as compared to Rs. 1131.30 millions during year-ago period.Net profit stood at Rs. 148.63  millions  compared to Rs. 137.24 millions in the corresponding previous quarter,high by 8.30%.OP of the company witnessed a marginal growth to 235.42 millions from 231.23 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1310.06 1131.30 15.80 1310.06 1131.30 15.80 5201.35 3406.08 52.71
Other Income 6.19 10.32 -40.02 6.19 10.32 -40.02 27.62 13.30 107.67
PBIDT 235.42 231.23 1.81 235.42 231.23 1.81 1079.38 815.32 32.39
Interest 1.82 27.89 -93.47 1.82 27.89 -93.47 64.07 56.18 14.04
PBDT 233.60 203.34 14.88 233.60 203.34 14.88 1015.31 759.14 33.74
Depreciation 30.38 22.27 36.42 30.38 22.27 36.42 100.80 41.88 140.69
PBT 203.22 181.07 12.23 203.22 181.07 12.23 914.51 717.26 27.50
TAX 54.59 43.83 24.55 54.59 43.83 24.55 195.04 177.27 10.02
Deferred Tax 4.63 3.23 43.34 4.63 3.23 43.34 27.83 1.63 1607.36
PAT 148.63 137.24 8.30 148.63 137.24 8.30 719.47 539.99 33.24
Equity 364.37 315.00 15.67 364.37 315.00 15.67 364.37 315.00 15.67
PBIDTM(%) 17.97 20.44 -12.08 17.97 20.44 -12.08 20.75 23.94 -13.31

Acutaas Chemicals Share Price

2361.75 16.10 (0.69%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×